IRWD - アイアンウッド・ファ―マシュ―ティカルズ （Ironwood Pharmaceuticals Inc.）

Ironwood Pharmaceuticals, Inc. (NASDAQ:NASDAQ:IRWD) Q2 2022 Earnings Conference Call August 4, 2022 08:30 a.m.

The following slide deck was published by Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals press release (IRWD): Q2 Non-GAAP EPS of $0.21 misses by $0.09.Revenue of $97.23M (-6.5% Y/Y) misses by $6.28M.Adjusted EBITDA was $56.0 million in the…

Ironwood Pharmaceuticals (IRWD) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open.The consensus EPS Estimate is $0.30 (-11.8% Y/Y) and the…

In trading on Friday, shares of Ironwood Pharmaceuticals Inc (Symbol: IRWD) crossed below their 200 day moving average of $11.79, changing hands as low as $11.05 per share. Ironwood Pharmaceuticals Inc shares are currently trading off about 7.9% on the day. The chart below sh

Ironwood Pharmaceuticals, Inc. (NASDAQ:NASDAQ:IRWD) Q2 2022 Earnings Conference Call August 4, 2022 08:30 a.m.

The following slide deck was published by Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals press release (IRWD): Q2 Non-GAAP EPS of $0.21 misses by $0.09.Revenue of $97.23M (-6.5% Y/Y) misses by $6.28M.Adjusted EBITDA was $56.0 million in the…

Ironwood Pharmaceuticals (IRWD) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open.The consensus EPS Estimate is $0.30 (-11.8% Y/Y) and the…

In trading on Friday, shares of Ironwood Pharmaceuticals Inc (Symbol: IRWD) crossed below their 200 day moving average of $11.79, changing hands as low as $11.05 per share. Ironwood Pharmaceuticals Inc shares are currently trading off about 7.9% on the day. The chart below sh

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) price on Friday, June 17, rose 0.35% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.31. A look at the stock’s price movement, the level at last check in today’s session was $11.27, moving within a range at $11.16 and $11.55. The beta … Ironwood Pharmaceuticals Inc. (IRWD) Has Recovered 10.43% From Its Low: Is This The Beginning Of A Trend? Read More »

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) traded at $12.15 at last check on Tuesday, June 07, made an upward move of 1.21% on its previous day’s price. Looking at the stock we see that its previous close was $12.00 and the beta (5Y monthly) reads 1.18 with the day’s price range being $11.951 – $12.44. The company … Ironwood Pharmaceuticals Inc.’s Stock Price Plummeted Recently, But There Might Be Trouble Ahead Read More »

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, presented new findings during the 2022 Digestive Disease Week (DDW) meeting that suggest colonic IW-3300 has the potential to help manage abdominopelvic visceral pain in patients with disorders of gut-brain interaction (DGBI) and related visceral pain disorders. The oral presentation, titled Colon-Targeted Delivery

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the company and its collaborators will present eight studies, including two oral presentations, during the Digestive Disease Week (DDW) 2022 meeting being held from May 21 through May 24, 2022 in San Diego, CA. One oral presentation will discuss the impact of novel guanylate cyclase-C agonist

Ironwood Pharmaceuticals released its earnings results on Thursday. The biotechnology company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.31 by…